Page last updated: 2024-08-25

zoledronic acid and Leukemia, Myelomonocytic, Chronic

zoledronic acid has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasegawa, D; Kawasaki, H; Manabe, A; Nakahata, T; Ohtsuka, Y; Tanizawa, T; Tsuji, K; Watanabe, S; Zaike, Y	1

Other Studies

1 other study(ies) available for zoledronic acid and Leukemia, Myelomonocytic, Chronic

Article	Year
RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro. Blood, 2005, Nov-01, Volume: 106, Issue:9 Topics: Adolescent; Bone Marrow; Cell Differentiation; Cell Proliferation; Diphosphonates; Flow Cytometry; Humans; Imidazoles; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Phosphates; ras Proteins; Tumor Cells, Cultured; Zoledronic Acid	2005

Article

Year

RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.

Blood, 2005, Nov-01, Volume: 106, Issue:9

Topics: Adolescent; Bone Marrow; Cell Differentiation; Cell Proliferation; Diphosphonates; Flow Cytometry; Humans; Imidazoles; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Phosphates; ras Proteins; Tumor Cells, Cultured; Zoledronic Acid

2005